PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

105 hedge funds and large institutions have $238M invested in Paratek Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 18 closing their positions.

Holders
105
Holders Change
-5
Holders Change %
-4.55%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
36
Reduced
28
Closed
18
Calls
$290K
Puts
$874K
Net Calls
-$584K
Net Calls Change
+$1K

Top Buyers

1
HCMT
1
Highland Capital Management (Texas)
Texas
$25.7M
2
APCM
2
Arbiter Partners Capital Management
New York
$9.62M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$1.86M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$1.51M
5
WIC
5
Water Island Capital
New York
$4.27M

Top Sellers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.1M
3
Deutsche Bank
3
Deutsche Bank
Germany
$2.75M
4
Man Group
4
Man Group
United Kingdom
$2.01M
5
Citadel Advisors
5
Citadel Advisors
Florida
$515K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
126
Concourse Financial Group Securities
Alabama
– – – –
WAM
127
Wolverine Asset Management
Illinois
– – – –
HCM
128
Highbridge Capital Management
New York
– – – –
2 3 4 5
6